Spots Global Cancer Trial Database for wbrt
Every month we try and update this database with for wbrt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy | NCT03626818 | Brain Metastase... | 18 Years - 75 Years | Guangdong Association of Clinical Trials | ||
| Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy | NCT00548756 | Brain Cancer | Whole Brain Rad... Observation Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Camrelizumab Combined With Local Treatment in NSCLC Patients With BM | NCT04291092 | NSCLC Stage IV Brain Metastase... Immunotherapy | Immunotherapy WBRT Chemotherapy | 18 Years - | Zhejiang Cancer Hospital | |
| Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | NCT01516983 | Non-small Cell ... Brain Metastase... | icotinib Whole brain rad... | 18 Years - 75 Years | Betta Pharmaceuticals Co., Ltd. | |
| Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) | NCT02338011 | Non-Small Cell ... Brain Metastase... EGFR Gene Mutat... | Gefitinib WBRT | 18 Years - | Shanghai Chest Hospital | |
| GM1 Prophylaxis for WBRT Related Cognitive Dysfunction | NCT04395339 | Brain Metastase... Radiotherapy Si... Cognitive Impai... Gangliosidosis,... Breast Cancer | Monosialotetrah... Control | 18 Years - 75 Years | Sun Yat-sen University | |
| A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases | NCT00649207 | Brain Diseases Brain Neoplasms Central Nervous... Neoplasm Metast... Nervous System ... | ABT-888 Whole Brain Rad... | 18 Years - 99 Years | AbbVie | |
| Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid) | NCT02882984 | Stage IV EGFR M... | Gefitinib 250mg... WBRT HFSRS | 18 Years - 99 Years | Sichuan Provincial People's Hospital | |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases | NCT00003563 | Metastatic Canc... | WBRT MGd | 18 Years - | Pharmacyclics LLC. | |
| Camrelizumab Combined With Local Treatment in NSCLC Patients With BM | NCT04291092 | NSCLC Stage IV Brain Metastase... Immunotherapy | Immunotherapy WBRT Chemotherapy | 18 Years - | Zhejiang Cancer Hospital | |
| Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma | NCT01503827 | Metastatic Mela... | WBRT | 18 Years - | Melanoma and Skin Cancer Trials Limited | |
| Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | NCT00030628 | Metastatic Canc... | radiation thera... surgery WBRT | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Toronto BNB Pilot Study | NCT02082587 | Brain Metastase... | 18 Years - | University Health Network, Toronto | ||
| IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy | NCT01727531 | Brain Metastasi... | Chloroquine dip... | 18 Years - | Main Line Health | |
| Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial | NCT03075072 | Brain Metastase... | Whole brain rad... Stereotactic ra... | 18 Years - 80 Years | Dana-Farber Cancer Institute | |
| IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases | NCT02556593 | Non-Small Cell ... | IMRT WBRT erlotinib | 18 Years - 75 Years | Sun Yat-sen University | |
| Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin | NCT05793489 | Brain Metastase... | Silibinin | 18 Years - | Istituto Clinico Humanitas | |
| Brain Mets - Capecitabine Plus Sunitinib and WBRT | NCT00570908 | Breast Cancer | sunitinib capecitabine WBRT | 18 Years - | Baylor Breast Care Center | |
| Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study | NCT01887795 | Multiple Brain ... Non-small-cell ... | Erlotinib WBRT | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Study of Tumour Focused Radiotherapy for Bladder Cancer | NCT02447549 | Bladder Cancer | WBRT SART DART | 16 Years - | Institute of Cancer Research, United Kingdom | |
| Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study | NCT01887795 | Multiple Brain ... Non-small-cell ... | Erlotinib WBRT | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases | NCT00003563 | Metastatic Canc... | WBRT MGd | 18 Years - | Pharmacyclics LLC. | |
| Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. | NCT00854867 | Solid Tumour Ne... Brain Metastase... | Whole Brain Rad... Whole brain rad... | 18 Years - | Mundipharma Research Limited | |
| Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | NCT00028925 | Lung Cancer | filgrastim carboplatin topotecan hydro... WBRT | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | NCT00470847 | Breast Cancer Brain Metastase... | Lapatinib Whole Brain Rad... Herceptin | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Tumour Focused Radiotherapy for Bladder Cancer | NCT02447549 | Bladder Cancer | WBRT SART DART | 16 Years - | Institute of Cancer Research, United Kingdom | |
| GM1 Prophylaxis for WBRT Related Cognitive Dysfunction | NCT04395339 | Brain Metastase... Radiotherapy Si... Cognitive Impai... Gangliosidosis,... Breast Cancer | Monosialotetrah... Control | 18 Years - 75 Years | Sun Yat-sen University | |
| A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis | NCT00977379 | Breast Cancer | WBRT Capecitabine Standard of Car... | 18 Years - | Hoffmann-La Roche | |
| Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. | NCT00854867 | Solid Tumour Ne... Brain Metastase... | Whole Brain Rad... Whole brain rad... | 18 Years - | Mundipharma Research Limited | |
| Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin | NCT05793489 | Brain Metastase... | Silibinin | 18 Years - | Istituto Clinico Humanitas | |
| Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer | NCT00871923 | Non-small Cell ... Brain Cancer | Tarceva (Erloti... Radiation Thera... | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| GM1 Prophylaxis for WBRT Related Cognitive Dysfunction | NCT04395339 | Brain Metastase... Radiotherapy Si... Cognitive Impai... Gangliosidosis,... Breast Cancer | Monosialotetrah... Control | 18 Years - 75 Years | Sun Yat-sen University | |
| IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases | NCT02556593 | Non-Small Cell ... | IMRT WBRT erlotinib | 18 Years - 75 Years | Sun Yat-sen University | |
| Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. | NCT00854867 | Solid Tumour Ne... Brain Metastase... | Whole Brain Rad... Whole brain rad... | 18 Years - | Mundipharma Research Limited | |
| Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases | NCT03297788 | SCLC Brain Metastase... | SRS WBRT | 18 Years - | University Hospital Heidelberg |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
